Gyre Therapeutics Ratios (2010-2026) | GYRE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	-0.62%	-0.35%	-0.57%	-0.50%			96.06%	95.49%	96.33%	96.30%	95.40%	96.40%	96.95%	96.24%	95.78%	95.95%	95.70%	94.67%	35.97%	37.23%
EBT Margin (Quarter)	-1,758.22%	-1,097.09%	-835.53%	-1,830.73%			-22.46%	25.15%	19.96%	34.92%	-369.38%	45.93%	23.92%	15.42%	-1.56%	21.01%	8.36%	24.96%	-52.95%	-41.02%
EBIT Margin (Quarter)	-1,759.19%	-1,097.39%	-832.50%	-1,851.51%			-22.13%	26.73%	16.96%	39.84%	-337.53%	29.70%	12.66%	16.61%	2.39%	10.30%	8.11%	22.66%	-22.41%	-41.54%
EBITDA Margin (Quarter)	-1,759.19%	-1,097.39%	-832.50%	-1,851.51%			-22.13%	26.73%	16.96%	39.84%	-337.53%	29.70%	12.66%	16.61%	2.39%	10.30%	8.11%	22.66%	-22.41%	-41.54%
Operating Margin (Quarter)	-1,759.19%	-1,097.39%	-832.50%	-1,851.51%			-22.13%	26.73%	16.96%	39.84%	-337.53%	29.70%	12.66%	16.61%	2.39%	10.30%	8.11%	22.66%	-22.41%	-41.54%
Net Margin (Quarter)	-1,760.42%	-1,097.78%	-835.53%	-1,830.73%			-29.47%	9.00%	6.32%	12.41%	-372.06%	27.72%	13.99%	4.41%	-0.36%	12.23%	1.65%	11.81%	-4.63%	-38.59%
FCF Margin (Quarter)	-1,777.65%	-960.94%	-724.43%	-1,517.63%			41.67%	34.80%	7.01%	17.50%	3.82%	9.76%	-27.55%	4.05%	-9.66%	-1.01%	6.73%	13.11%	-15.51%	13.42%
Efficiency
Inventory Average (Quarter)												4.61M	5.29M	6.01M	6.36M	7.11M	8.37M	8.86M	9.51M	10.76M
Assets Average (Quarter)	110.43M	90.16M	67.10M	47.97M	61.82M	57.20M	57.89M	51.75M	15.57M	11.18M	63.25M	119.27M	121.47M	123.08M	125.32M	127.60M	141.22M	156.01M	162.76M	164.07M
Equity Average (Quarter)	94.63M	72.95M	60.10M	43.27M	53.07M	54.22M	50.80M	74.77M	77.40M	81.39M	49.63M	51.36M	91.06M	95.91M	80.90M	83.81M	116.87M	115.68M	122.10M	121.51M
Invested Capital (Quarter)	85.16M	60.74M	59.47M	27.08M	79.06M	29.38M	72.22M	77.33M	77.47M	85.32M	13.95M	88.77M	93.35M	98.47M	63.32M	104.30M	129.44M	101.92M	142.28M	136.99M
Asset Utilization Ratio (Quarter)	0.05	0.08	0.11	0.14	0.09	0.06	1.77	2.44	10.00	16.80	1.79	0.97	0.92	0.85	0.84	0.79	0.72	0.69	0.72	0.71
Leverage & Solvency
Interest Coverage Ratio (Quarter)								10.36				25.62
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.84	0.77	1.07	0.67	0.95	0.95	0.85	4.12	6.25	8.56	0.12	0.73	0.77	0.79	0.50	0.80	0.85	0.64	0.86	0.85
Times Interest Earned (Quarter)								10.36				25.62
Dividends & Payouts
FCF Payout Ratio (Quarter)								0.89	1.70	0.27
Valuation
Enterprise Value (Quarter)	-86.52M	-69.90M	-49.35M	-34.82M	-75.39M	-23.10M	4.52M	-8.10M	-11.53M	-2.23M	19.20M	15.85M	7.89M	10.20M	8.43M	6.38M	-9.10M	-11.32M	-16.17M	-14.13M
Return Ratios
Return on Sales (Quarter)	-0.18%	-0.11%	-0.08%	-0.18%	-0.02%	0.04%	0.00%	0.00%	0.00%	0.00%	-0.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%
Return on Capital Employed (Quarter)	-81.48%	-118.53%	-166.04%	-230.48%	-15.15%	20.43%	20.16%	68.07%	-125.11%	20.67%	-155.61%	-65.96%	-63.84%	-70.25%	15.28%	9.54%	7.52%	8.59%	2.10%	-5.96%
Return on Invested Capital (Quarter)				-0.02%	0.00%		0.00%	0.00%	0.00%	-0.01%	-0.02%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.02%	0.00%	0.00%	0.00%	0.00%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.02%	-0.02%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Gyre Therapeutics Ratios (2010-2026) | GYRE

Create an account

Sign In

Reset Password